Chinese Traditional and Herbal Drugs
|
2025, 56(11): 4103-4114
Research progress on mechanisms of obesity regulation by puerarin
Full
CHEN Yan1, FENG Yanchen2, LIAO Ziyun3, LIU Feixiang4, SUN Xinyu1
Affiliations
1 Department of Endocrinology, Henan Provincial Traditional Chinese Medicine Hospital, Zhengzhou 450002, China;
2 First Clinical Medical College, Henan University of Chinese Medicine, Zhengzhou 450046, China;
3 Education Office, Zhengzhou People’s Hospital, Zhengzhou 450046, China;
4 Department of Neuropsychiatry and Psychology, the First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou 451472, China
doi: 10.7501/j.issn.0253-2670.2025.11.029
Outline
Obesity is a complex metabolic disease characterized by dysregulated energy metabolism, involving multiple pathological mechanisms such as imbalanced glucose and lipid metabolism, insulin resistance, chronic low-grade inflammation, oxidative stress, and gut microbiota dysbiosis. Puerarin, the primary isoflavone compound extracted from the leguminous plant Gegen (Puerariae Lobatae Radix), has attracted significant attention in recent years due to its prominent anti-obesity potential. Current studies indicate that puerarin not only effectively regulates lipid metabolism, reduces fat synthesis and promotes fatty acid oxidation and decomposition but also improves glucose metabolism, enhances insulin sensitivity, and alleviates insulin resistance. Moreover, puerarin modulates gut microbiota structure and hypothalamic orexin secretion, improving brain-gut axis function, which subsequently reduces fat absorption and accumulation, and lowers chronic inflammation and oxidative stress levels. However, despite the significant anti-obesity effects observed in vivo and in vitro experiments, the specific molecular mechanisms of puerarin remain incompletely understood. Therefore, this review systematically summarizes recent research on anti-obesity mechanisms of puerarin, aiming to explore its potential pathways of action and provide an important theoretical foundation and practical guidance for the clinical translation and drug development of puerarin in obesity prevention and treatment.
puerarin
/
obesity
/
glucose and lipid metabolism
/
insulin resistance
/
gut microbiota
陈焱, 封俨宸, 廖紫云, 刘飞祥, 孙新宇.
葛根素调节肥胖机制的研究进展.
中草药,
2025
, 56
(11)
: 4103
-4114
.
DOI: 10.7501/j.issn.0253-2670.2025.11.029
CHEN Yan, FENG Yanchen, LIAO Ziyun, LIU Feixiang, SUN Xinyu.
Research progress on mechanisms of obesity regulation by puerarin[J].
Chinese Traditional and Herbal Drugs,
2025
, 56
(11)
: 4103
-4114
.
DOI: 10.7501/j.issn.0253-2670.2025.11.029
Year 2025 volume 56 Issue 11
46
8
Cite this Article
BibTeX
Article Info
doi: 10.7501/j.issn.0253-2670.2025.11.029
- Receive Date:2025-03-03
- Online Date:2026-11-13